Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $27.1B
1-Year Return 23.24%
This Quarter Return
+6.14%
1 Year Return
+23.24%
3 Year Return
+64.59%
5 Year Return
+118.48%
10 Year Return
+210.79%
AUM
$12.7B
AUM Growth
+$209M
Cap. Flow
-$855M
Cap. Flow %
-6.73%
Top 10 Hldgs %
33.81%
Holding
1,213
New
39
Increased
447
Reduced
292
Closed
29

Sector Composition

1 Real Estate 73.52%
2 Industrials 3.95%
3 Technology 3.76%
4 Financials 2.75%
5 Consumer Discretionary 2.57%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
INSY
1101
DELISTED
Insys Therapeutics, Inc.
INSY
$3K ﹤0.01%
405
IMUX icon
1102
Immunic
IMUX
$76M
$2K ﹤0.01%
6
INO icon
1103
Inovio Pharmaceuticals
INO
$146M
$2K ﹤0.01%
42
KALA icon
1104
KALA BIO
KALA
$102M
$2K ﹤0.01%
3
MCRB icon
1105
Seres Therapeutics
MCRB
$165M
$2K ﹤0.01%
11
MRSN icon
1106
Mersana Therapeutics
MRSN
$35.5M
$2K ﹤0.01%
5
NERV icon
1107
Minerva Neurosciences
NERV
$16.2M
$2K ﹤0.01%
27
NVAX icon
1108
Novavax
NVAX
$1.27B
$2K ﹤0.01%
87
PACB icon
1109
Pacific Biosciences
PACB
$372M
$2K ﹤0.01%
642
RIGL icon
1110
Rigel Pharmaceuticals
RIGL
$720M
$2K ﹤0.01%
81
SVRA icon
1111
Savara
SVRA
$619M
$2K ﹤0.01%
169
VCYT icon
1112
Veracyte
VCYT
$2.48B
$2K ﹤0.01%
188
PETQ
1113
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$2K ﹤0.01%
73
MRNS
1114
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$2K ﹤0.01%
56
NSTG
1115
DELISTED
NanoString Technologies, Inc.
NSTG
$2K ﹤0.01%
140
PRTK
1116
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$2K ﹤0.01%
173
CNCE
1117
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$2K ﹤0.01%
126
NH
1118
DELISTED
NantHealth, Inc
NH
$2K ﹤0.01%
40
ACHN
1119
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
$2K ﹤0.01%
762
SNNA
1120
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
$2K ﹤0.01%
113
AKAO
1121
DELISTED
Achaogen, Inc.
AKAO
$2K ﹤0.01%
234
SGYP
1122
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$2K ﹤0.01%
1,363
CORI
1123
DELISTED
Corium International, Inc.
CORI
$2K ﹤0.01%
198
PDLI
1124
DELISTED
PDL BioPharma, Inc.
PDLI
$2K ﹤0.01%
853
ABUS icon
1125
Arbutus Biopharma
ABUS
$769M
$2K ﹤0.01%
304